G
This biotechnology company develops protein therapeutics targeting rheumatoid arthritis and KRAS-mutant cancers through an open innovation strategy. Their dual-action antibiotic drugs aim to alleviate symptoms of rheumatoid arthritis while addressing osteoporosis complications and inducing apoptosis in cancer cells.
성남시, 대한민국
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This biotechnology company develops protein therapeutics targeting rheumatoid arthritis and KRAS-mutant cancers through an open innovation strategy. Their dual-action antibiotic drugs aim to alleviate symptoms of rheumatoid arthritis while addressing osteoporosis complications and inducing apoptosis in cancer cells.